2019 1. Highlights Health and safety: There were 3 lost time injuries in H1 2019 Revenue: 528mTHB in H1 2019 compared to 548mTHB in H1 2018 a decrease of 4% EBITDA: 98mTHB in H1 2019 compared to
Providing Compliance Unit of an Intermediary
. Net profit in Q3/2017 was Baht 78 million, a decrease of 52% YoY due to 1) higher cost per unit resulted from lower capacity utilization YoY; and 2) higher depreciation resulted from additional
functional drinks (+26.2 YoY). Domestic beverage continued showing strong growth at 4.6% YoY from both energy drinks and functional drinks. Speed-up health and hygiene innovations made a turnaround of domestic
Derivative Warrants | ALIHEA41C2601A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN JANUARY 2026
Derivative Warrants | ALIHEA41C2502A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN FEBRUARY 2025
Derivative Warrants | ALIHEA28C2409A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN SEPTEMBER 2024
Derivative Warrants | ALIHEA41C2410A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2024
Derivative Warrants | ALIHEA41C2310A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2023